Opioids Drug Market - Global Outlook and Forecast 2021-2027

Opioids Drug Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Opioids Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioids Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioids Drug Overall Market Size
2.1 Global Opioids Drug Market Size: 2021 VS 2027
2.2 Global Opioids Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Opioids Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Opioids Drug Players in Global Market
3.2 Top Global Opioids Drug Companies Ranked by Revenue
3.3 Global Opioids Drug Revenue by Companies
3.4 Global Opioids Drug Sales by Companies
3.5 Global Opioids Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Opioids Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Opioids Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioids Drug Players in Global Market
3.8.1 List of Global Tier 1 Opioids Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioids Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioids Drug Market Size Markets, 2021 & 2027
4.1.2 Oxycodone
4.1.3 Hydromorphone
4.1.4 Codeine
4.1.5 Fentanyl
4.2 By Type - Global Opioids Drug Revenue & Forecasts
4.2.1 By Type - Global Opioids Drug Revenue, 2016-2021
4.2.2 By Type - Global Opioids Drug Revenue, 2022-2027
4.2.3 By Type - Global Opioids Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Opioids Drug Sales & Forecasts
4.3.1 By Type - Global Opioids Drug Sales, 2016-2021
4.3.2 By Type - Global Opioids Drug Sales, 2022-2027
4.3.3 By Type - Global Opioids Drug Sales Market Share, 2016-2027
4.4 By Type - Global Opioids Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Opioids Drug Market Size, 2021 & 2027
5.1.2 Pain Relief
5.1.3 Anesthesia
5.1.4 Others
5.2 By Application - Global Opioids Drug Revenue & Forecasts
5.2.1 By Application - Global Opioids Drug Revenue, 2016-2021
5.2.2 By Application - Global Opioids Drug Revenue, 2022-2027
5.2.3 By Application - Global Opioids Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Opioids Drug Sales & Forecasts
5.3.1 By Application - Global Opioids Drug Sales, 2016-2021
5.3.2 By Application - Global Opioids Drug Sales, 2022-2027
5.3.3 By Application - Global Opioids Drug Sales Market Share, 2016-2027
5.4 By Application - Global Opioids Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Opioids Drug Market Size, 2021 & 2027
6.2 By Region - Global Opioids Drug Revenue & Forecasts
6.2.1 By Region - Global Opioids Drug Revenue, 2016-2021
6.2.2 By Region - Global Opioids Drug Revenue, 2022-2027
6.2.3 By Region - Global Opioids Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Opioids Drug Sales & Forecasts
6.3.1 By Region - Global Opioids Drug Sales, 2016-2021
6.3.2 By Region - Global Opioids Drug Sales, 2022-2027
6.3.3 By Region - Global Opioids Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Opioids Drug Revenue, 2016-2027
6.4.2 By Country - North America Opioids Drug Sales, 2016-2027
6.4.3 US Opioids Drug Market Size, 2016-2027
6.4.4 Canada Opioids Drug Market Size, 2016-2027
6.4.5 Mexico Opioids Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Opioids Drug Revenue, 2016-2027
6.5.2 By Country - Europe Opioids Drug Sales, 2016-2027
6.5.3 Germany Opioids Drug Market Size, 2016-2027
6.5.4 France Opioids Drug Market Size, 2016-2027
6.5.5 U.K. Opioids Drug Market Size, 2016-2027
6.5.6 Italy Opioids Drug Market Size, 2016-2027
6.5.7 Russia Opioids Drug Market Size, 2016-2027
6.5.8 Nordic Countries Opioids Drug Market Size, 2016-2027
6.5.9 Benelux Opioids Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Opioids Drug Revenue, 2016-2027
6.6.2 By Region - Asia Opioids Drug Sales, 2016-2027
6.6.3 China Opioids Drug Market Size, 2016-2027
6.6.4 Japan Opioids Drug Market Size, 2016-2027
6.6.5 South Korea Opioids Drug Market Size, 2016-2027
6.6.6 Southeast Asia Opioids Drug Market Size, 2016-2027
6.6.7 India Opioids Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Opioids Drug Revenue, 2016-2027
6.7.2 By Country - South America Opioids Drug Sales, 2016-2027
6.7.3 Brazil Opioids Drug Market Size, 2016-2027
6.7.4 Argentina Opioids Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioids Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Opioids Drug Sales, 2016-2027
6.8.3 Turkey Opioids Drug Market Size, 2016-2027
6.8.4 Israel Opioids Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Opioids Drug Market Size, 2016-2027
6.8.6 UAE Opioids Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Opioids Drug Major Product Offerings
7.1.4 Teva Opioids Drug Sales and Revenue in Global (2016-2021)
7.1.5 Teva Key News
7.2 Purdue Pharma
7.2.1 Purdue Pharma Corporate Summary
7.2.2 Purdue Pharma Business Overview
7.2.3 Purdue Pharma Opioids Drug Major Product Offerings
7.2.4 Purdue Pharma Opioids Drug Sales and Revenue in Global (2016-2021)
7.2.5 Purdue Pharma Key News
7.3 Mallinckrodt
7.3.1 Mallinckrodt Corporate Summary
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Opioids Drug Major Product Offerings
7.3.4 Mallinckrodt Opioids Drug Sales and Revenue in Global (2016-2021)
7.3.5 Mallinckrodt Key News
7.4 Amneal Pharma
7.4.1 Amneal Pharma Corporate Summary
7.4.2 Amneal Pharma Business Overview
7.4.3 Amneal Pharma Opioids Drug Major Product Offerings
7.4.4 Amneal Pharma Opioids Drug Sales and Revenue in Global (2016-2021)
7.4.5 Amneal Pharma Key News
7.5 Collegium
7.5.1 Collegium Corporate Summary
7.5.2 Collegium Business Overview
7.5.3 Collegium Opioids Drug Major Product Offerings
7.5.4 Collegium Opioids Drug Sales and Revenue in Global (2016-2021)
7.5.5 Collegium Key News
7.6 J&J
7.6.1 J&J Corporate Summary
7.6.2 J&J Business Overview
7.6.3 J&J Opioids Drug Major Product Offerings
7.6.4 J&J Opioids Drug Sales and Revenue in Global (2016-2021)
7.6.5 J&J Key News
7.7 Endo
7.7.1 Endo Corporate Summary
7.7.2 Endo Business Overview
7.7.3 Endo Opioids Drug Major Product Offerings
7.4.4 Endo Opioids Drug Sales and Revenue in Global (2016-2021)
7.7.5 Endo Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Opioids Drug Major Product Offerings
7.8.4 Pfizer Opioids Drug Sales and Revenue in Global (2016-2021)
7.8.5 Pfizer Key News
7.9 INSYS
7.9.1 INSYS Corporate Summary
7.9.2 INSYS Business Overview
7.9.3 INSYS Opioids Drug Major Product Offerings
7.9.4 INSYS Opioids Drug Sales and Revenue in Global (2016-2021)
7.9.5 INSYS Key News
7.10 Mylan
7.10.1 Mylan Corporate Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan Opioids Drug Major Product Offerings
7.10.4 Mylan Opioids Drug Sales and Revenue in Global (2016-2021)
7.10.5 Mylan Key News
7.11 Hikma
7.11.1 Hikma Corporate Summary
7.11.2 Hikma Opioids Drug Business Overview
7.11.3 Hikma Opioids Drug Major Product Offerings
7.11.4 Hikma Opioids Drug Sales and Revenue in Global (2016-2021)
7.11.5 Hikma Key News
7.12 Egalet
7.12.1 Egalet Corporate Summary
7.12.2 Egalet Opioids Drug Business Overview
7.12.3 Egalet Opioids Drug Major Product Offerings
7.12.4 Egalet Opioids Drug Sales and Revenue in Global (2016-2021)
7.12.5 Egalet Key News
8 Global Opioids Drug Production Capacity, Analysis
8.1 Global Opioids Drug Production Capacity, 2016-2027
8.2 Opioids Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioids Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Opioids Drug Supply Chain Analysis
10.1 Opioids Drug Industry Value Chain
10.2 Opioids Drug Upstream Market
10.3 Opioids Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioids Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Opioids Drug in Global Market
Table 2. Top Opioids Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Opioids Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Opioids Drug Revenue Share by Companies, 2016-2021
Table 5. Global Opioids Drug Sales by Companies, (M Units), 2016-2021
Table 6. Global Opioids Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Opioids Drug Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Opioids Drug Product Type
Table 9. List of Global Tier 1 Opioids Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioids Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Opioids Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Opioids Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Opioids Drug Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Opioids Drug Sales (M Units), 2016-2021
Table 15. By Type - Global Opioids Drug Sales (M Units), 2022-2027
Table 16. By Application - Global Opioids Drug Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Opioids Drug Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Opioids Drug Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Opioids Drug Sales (M Units), 2016-2021
Table 20. By Application - Global Opioids Drug Sales (M Units), 2022-2027
Table 21. By Region - Global Opioids Drug Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Opioids Drug Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Opioids Drug Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Opioids Drug Sales (M Units), 2016-2021
Table 25. By Region - Global Opioids Drug Sales (M Units), 2022-2027
Table 26. By Country - North America Opioids Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Opioids Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Opioids Drug Sales, (M Units), 2016-2021
Table 29. By Country - North America Opioids Drug Sales, (M Units), 2022-2027
Table 30. By Country - Europe Opioids Drug Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Opioids Drug Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Opioids Drug Sales, (M Units), 2016-2021
Table 33. By Country - Europe Opioids Drug Sales, (M Units), 2022-2027
Table 34. By Region - Asia Opioids Drug Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Opioids Drug Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Opioids Drug Sales, (M Units), 2016-2021
Table 37. By Region - Asia Opioids Drug Sales, (M Units), 2022-2027
Table 38. By Country - South America Opioids Drug Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Opioids Drug Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Opioids Drug Sales, (M Units), 2016-2021
Table 41. By Country - South America Opioids Drug Sales, (M Units), 2022-2027
Table 42. By Country - Middle East & Africa Opioids Drug Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Opioids Drug Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Opioids Drug Sales, (M Units), 2016-2021
Table 45. By Country - Middle East & Africa Opioids Drug Sales, (M Units), 2022-2027
Table 46. Teva Corporate Summary
Table 47. Teva Opioids Drug Product Offerings
Table 48. Teva Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Purdue Pharma Corporate Summary
Table 50. Purdue Pharma Opioids Drug Product Offerings
Table 51. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Mallinckrodt Corporate Summary
Table 53. Mallinckrodt Opioids Drug Product Offerings
Table 54. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Amneal Pharma Corporate Summary
Table 56. Amneal Pharma Opioids Drug Product Offerings
Table 57. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Collegium Corporate Summary
Table 59. Collegium Opioids Drug Product Offerings
Table 60. Collegium Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. J&J Corporate Summary
Table 62. J&J Opioids Drug Product Offerings
Table 63. J&J Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Endo Corporate Summary
Table 65. Endo Opioids Drug Product Offerings
Table 66. Endo Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer Opioids Drug Product Offerings
Table 69. Pfizer Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. INSYS Corporate Summary
Table 71. INSYS Opioids Drug Product Offerings
Table 72. INSYS Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Mylan Corporate Summary
Table 74. Mylan Opioids Drug Product Offerings
Table 75. Mylan Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. Hikma Corporate Summary
Table 77. Hikma Opioids Drug Product Offerings
Table 78. Hikma Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Egalet Corporate Summary
Table 80. Egalet Opioids Drug Product Offerings
Table 81. Egalet Opioids Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 82. Opioids Drug Production Capacity (M Units) of Key Manufacturers in Global Market, 2019-2021 (M Units)
Table 83. Global Opioids Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 84. Global Opioids Drug Production by Region, 2016-2021 (M Units)
Table 85. Global Opioids Drug Production by Region, 2022-2027 (M Units)
Table 86. Opioids Drug Market Opportunities & Trends in Global Market
Table 87. Opioids Drug Market Drivers in Global Market
Table 88. Opioids Drug Market Restraints in Global Market
Table 89. Opioids Drug Raw Materials
Table 90. Opioids Drug Raw Materials Suppliers in Global Market
Table 91. Typical Opioids Drug Downstream
Table 92. Opioids Drug Downstream Clients in Global Market
Table 93. Opioids Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Opioids Drug Segment by Type
Figure 2. Opioids Drug Segment by Application
Figure 3. Global Opioids Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Opioids Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Opioids Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Opioids Drug Sales in Global Market: 2016-2027 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Opioids Drug Revenue in 2020
Figure 9. By Type - Global Opioids Drug Sales Market Share, 2016-2027
Figure 10. By Type - Global Opioids Drug Revenue Market Share, 2016-2027
Figure 11. By Type - Global Opioids Drug Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Opioids Drug Sales Market Share, 2016-2027
Figure 13. By Application - Global Opioids Drug Revenue Market Share, 2016-2027
Figure 14. By Application - Global Opioids Drug Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Opioids Drug Sales Market Share, 2016-2027
Figure 16. By Region - Global Opioids Drug Revenue Market Share, 2016-2027
Figure 17. By Country - North America Opioids Drug Revenue Market Share, 2016-2027
Figure 18. By Country - North America Opioids Drug Sales Market Share, 2016-2027
Figure 19. US Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Opioids Drug Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Opioids Drug Sales Market Share, 2016-2027
Figure 24. Germany Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 25. France Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Opioids Drug Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Opioids Drug Sales Market Share, 2016-2027
Figure 33. China Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 37. India Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Opioids Drug Revenue Market Share, 2016-2027
Figure 39. By Country - South America Opioids Drug Sales Market Share, 2016-2027
Figure 40. Brazil Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Opioids Drug Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Opioids Drug Sales Market Share, 2016-2027
Figure 44. Turkey Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Opioids Drug Revenue, (US$, Mn), 2016-2027
Figure 48. Global Opioids Drug Production Capacity (M Units), 2016-2027
Figure 49. The Percentage of Production Opioids Drug by Region, 2020 VS 2027
Figure 50. Opioids Drug Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs